Position in INVA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,954,245
+$7,390,665 QoQ
Shares Held
350,253
+1348.0% QoQ
Ownership
0.485%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#37
of 303 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INVA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BRIDGEWAY CAPITAL MANAGEMENT, LLC holds $87,496,321 across 108 Biotechnology names. INVA ranks #2 (9.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GLUE |
Monte Rosa Therapeutics, Inc.
|
552,566 | $13,372,097 | |
| 2 | INVA |
Innoviva, Inc.
This page
|
350,253 | $7,954,245 | |
| 3 | PBYI |
Puma Biotechnology, Inc.
|
791,616 | $6,420,005 | |
| 4 | RIGL |
Rigel Pharmaceuticals Inc
|
124,184 | $4,858,078 | |
| 5 | EXEL |
Exelixis, Inc.
|
66,100 | $3,596,501 | |
| 6 | CRMD |
CorMedix Inc.
|
434,132 | $3,407,936 | |
| 7 | KROS |
Keros Therapeutics, Inc.
|
265,017 | $2,835,681 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
22,000 | $1,794,540 |
All Filings in INVA
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,954,245 | 350,253 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $563,580 | 24,188 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,066,726 | 103,388 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,091,231 | 114,588 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,302,072 | 114,588 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,937,567 | 162,028 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $3,224,653 | 185,859 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $6,278,723 | 325,154 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $9,155,726 | 558,276 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $8,214,603 | 539,016 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $8,342,821 | 520,126 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $6,485,971 | 499,305 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $6,136,916 | 482,083 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $5,347,406 | 475,325 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $4,573,635 | 345,180 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,805,355 | 155,500 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,295,180 | 155,500 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,008,925 | 155,500 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,682,375 | 155,500 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,598,405 | 155,500 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $179,694 | 13,400 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $470,830 | 39,400 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $413,826 | 33,400 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $308,275 | 29,500 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $373,266 | 26,700 | Shares | Sole | 2020-08-31 | |
| 2020-03-31 | $362,208 | 30,800 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||